Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112857515 | 11285751 | 5 | F | 201412 | 20160711 | 20150721 | 20160719 | EXP | DE-ABBVIE-15K-062-1428133-00 | ABBVIE | 54.67 | YR | M | Y | 0.00000 | 20160719 | CN | COUNTRY NOT SPECIFIED | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112857515 | 11285751 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q3W | |||||
| 112857515 | 11285751 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q3W | |||||
| 112857515 | 11285751 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q3W | |||||
| 112857515 | 11285751 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | 300 | MG | QD | |||||||||
| 112857515 | 11285751 | 5 | C | VALSARTAN. | VALSARTAN | 1 | 0 | 320 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112857515 | 11285751 | 1 | Psoriasis |
| 112857515 | 11285751 | 4 | Product used for unknown indication |
| 112857515 | 11285751 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112857515 | 11285751 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112857515 | 11285751 | Abasia | |
| 112857515 | 11285751 | Arthralgia | |
| 112857515 | 11285751 | Arthropathy | |
| 112857515 | 11285751 | Cartilage atrophy | |
| 112857515 | 11285751 | Joint effusion | |
| 112857515 | 11285751 | Joint injury | |
| 112857515 | 11285751 | Joint swelling | |
| 112857515 | 11285751 | Ligament rupture | |
| 112857515 | 11285751 | Ligament sprain | |
| 112857515 | 11285751 | Meniscus injury | |
| 112857515 | 11285751 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112857515 | 11285751 | 1 | 20140915 | 201506 | 0 | |
| 112857515 | 11285751 | 2 | 2015 | 20160416 | 0 | |
| 112857515 | 11285751 | 3 | 20160606 | 0 |